- Conditions
- COVID-19
- Interventions
- Phlebotomy
- Diagnostic Test
- Lead sponsor
- LifeBridge Health
- Other
- Eligibility
- 3 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–17
of 17
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Red Blood Cell Donation
- Interventions
- Not listed
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 2
- States / cities
- Norfolk, Virginia • Milwaukee, Wisconsin
- Conditions
- Coagulopathy
- Interventions
- RapidTEG test
- Procedure
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 3
- States / cities
- San Francisco, California • Portland, Oregon • Houston, Texas
- Conditions
- Thrombosis, Arterial Occlusive Diseases, Thromboelastography (TEG), Peripheral Arterial Disease(PAD), Stent Thrombosis, Platelet Inhibition, PRU(Platelet Reactivity Unit)
- Interventions
- Aspirin, Clopidogrel, Ticagrelor, Platelet Reactivity Testing, Thromboelastography with Platelet Mapping
- Drug · Diagnostic Test
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 514 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Transmission, Blood, Recipient/Donor
- Interventions
- Not listed
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 161 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Surgery
- Interventions
- TEG 6s Citrated K, KH, RTH, FFH Cartridge, Clauss Fibrinogen
- Diagnostic Test
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 338 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 7
- States / cities
- San Francisco, California • Aurora, Colorado • New Orleans, Louisiana + 4 more
- Conditions
- Healthy
- Interventions
- TEG 6s Citrated K, KH, RTH, and FFH Cartridge, Clauss Fibrinogen
- Diagnostic Test
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 181 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 3
- States / cities
- Oakland, California • Maywood, Illinois • New Orleans, Louisiana
- Conditions
- DOAC Eligible Subjects
- Interventions
- TEG6s DOAC Cartridge
- Device
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 385 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 4
- States / cities
- South Bend, Indiana • Duluth, Minnesota • Spartanburg, South Carolina + 1 more
- Conditions
- Liver Cancer, Esophageal Cancer, Colorectal Cancer, Lung Adenocarcinoma, Control, Pancreas Cancer, Biliary Cancer
- Interventions
- TEG indices
- Diagnostic Test
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2028
- U.S. locations
- 2
- States / cities
- Aurora, Colorado • Highlands Ranch, Colorado
- Conditions
- Apheresis Related Hypotension
- Interventions
- Updated Plasma Collection Feature, Current Plasma Collection Approach
- Device
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years to 66 Years
- Enrollment
- 3,443 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020
- U.S. locations
- 3
- States / cities
- Wichita, Kansas • Charlotte, North Carolina • Spokane, Washington
- Conditions
- Transmission, Blood, Recipient/Donor
- Interventions
- POLFA (Needle Assembly), Kawasumi (Needle Assembly)
- Device
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 62 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015
- U.S. locations
- 3
- States / cities
- Braintree, Massachusetts • Cincinnati, Ohio • Norfolk, Virginia
- Conditions
- Coagulation, Platelet Function
- Interventions
- Not listed
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 2
- States / cities
- Baltimore, Maryland • Knoxville, Tennessee
- Conditions
- Blood Donors
- Interventions
- SOLX (Investigational), AS-3 (Control)
- Drug
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 170 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 2
- States / cities
- Cincinnati, Ohio • Norfolk, Virginia
- Conditions
- Transmission, Blood, Recipient/Donor
- Interventions
- OrthoPat Advance
- Device
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 84 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Primary Total Hip and Knee Arthroplasty
- Interventions
- Arixtra, Pneumatic compression stockings, Aspirin
- Drug · Device
- Lead sponsor
- LifeBridge Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 2
- States / cities
- Baltimore, Maryland
- Conditions
- Acute Coagulopathy
- Interventions
- Blood product transfusion based on conventional coagulation tests., Blood product transfusion based on rapid thrombelastography (r-TEG) results.
- Biological
- Lead sponsor
- Denver Health and Hospital Authority
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Coagulation
- Interventions
- Not listed
- Lead sponsor
- Haemonetics Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 159 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011
- U.S. locations
- 1
- States / cities
- Manhasset, New York